Skip to main content
Figure 4 | BMC Cancer

Figure 4

From: The synthetic peptide P111-136 derived from the C-terminal domain of heparin affin regulatory peptide inhibits tumour growth of prostate cancer PC-3 cells

Figure 4

Inhibition of tumour angiogenesis by peptide P111-136. For immunohistochemical analysis, tumour sections were prepared and stained with anti-CD31 antibodies. (A), untreated tumours and (B), tumours treated with P111-136. Scale bar, 100 μm. (C), angiogenesis was quantified by image analysis of CD31-labelled endothelial cells. The data are mean areas +/- SD obtained from 5 control mice and 5 mice treated with P111-136. **p < 0.01 versus control.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us